Psyence Biomedical PBM
NASDAQ PBM
$4.54 +0.30 (+7.09%)
As of: Oct 21, 2026 · 2:25 PM EDT

Psyence Biomedical (PBM) Total Debt (2023)

Updated

Psyence Biomedical (PBM) recorded Total Debt of $1.61 million in the quarter ended Sep 30, 2023.

Analysis

Psyence Biomedical (PBM) Total Debt (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,135.43 Bn 1,104.02 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 616.54 Bn 535.06 Bn 17.26 Bn 49.04 Bn
3 AbbVie 501.55 Bn 474.66 Bn 12.70 Bn 70.82 Bn
4 Merck 367.19 Bn 321.57 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 297.91 Bn 261.90 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 261.40 Bn 235.09 Bn 12.86 Bn 32.35 Bn
7 Amgen 236.18 Bn 191.58 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 190.55 Bn 164.75 Bn 6.22 Bn 26.25 Bn
9 Pfizer 169.40 Bn 116.05 Bn 10.94 Bn 63.19 Bn
10 Psyence Biomedical 2.50 Mn -20.16 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 1.61 Mn
API Access

Psyence Biomedical Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=PBM&period=max&api_key=YOUR_API_KEY